Follow
Pavitra Ramdas
Pavitra Ramdas
Vaccine Research Centre, NIH
Verified email at nih.gov
Title
Cited by
Cited by
Year
From entry to egress: Strategic exploitation of the cellular processes by HIV-1
P Ramdas, AK Sahu, T Mishra, V Bhardwaj, A Chande
Frontiers in Microbiology 11, 559792, 2020
412020
SARS CoV-2 nucleoprotein enhances the infectivity of lentiviral spike particles
T Mishra, M Sreepadmanabh, P Ramdas, AK Sahu, A Kumar, A Chande
Frontiers in cellular and infection microbiology 11, 663688, 2021
202021
Coelacanth SERINC2 Inhibits HIV-1 Infectivity and Is Counteracted by Envelope Glycoprotein from Foamy Virus
P Ramdas, V Bhardwaj, A Singh, N Vijay, A Chande
Journal of Virology 95 (13), 10.1128/jvi. 00229-21, 2021
112021
SERINC5 mediates a postintegration block to HIV-1 gene expression in macrophages
P Ramdas, A Chande
MBio 14 (2), e00166-23, 2023
32023
Improved loss-of-function CRISPR-Cas9 genome editing in human cells concomitant with inhibition of TGF-β signaling
T Mishra, V Bhardwaj, N Ahuja, P Gadgil, P Ramdas, S Shukla, A Chande
Molecular Therapy-Nucleic Acids 28, 202-218, 2022
22022
SARS CoV-2 nucleoprotein enhances the infectivity of lentiviral spike particles (preprint)
T Mishra, M Sreepadmanabh, P Ramdas, AK Sahu, A Kumar, A Chande
2021
Coevolution of retroviruses with SERINCs following whole-genome duplication divergence
P Ramdas, V Bhardwaj, A Singh, N Vijay, A Chande
bioRxiv, 2020.02. 24.962506, 2020
2020
Evidence for Inhibition of HIV-1 Infectivity by a WGD-Proximate SERINC2
P Ramdas, V Bhardwaj, A Singh, N Vijay, A Chande
SERINC2, 0
The system can't perform the operation now. Try again later.
Articles 1–8